My mhealth embraces the present-day fast-changing healthcare scenario. It has proved to be the leading innovator in transforming the management of chronic diseases. This specialization in developing new innovative digital therapeutics and services, such as the following-with-COPD, heart-related conditions, asthma, diabetes, and cancer, is excellent in delivering patient care by using cutting-edge technology around-the-clock. my mhealth has expanded its reach from working with the NHS to working with other global health services, insurers, and pharmaceutical partners. Finally, my mhealth is into a new age of healthcare in which patients need not visit the doctor; they can simply go online and manage their health via digital solutions.

Digital Hub Empower Patients

Digital hub aims to transform healthcare delivery through the provision of accessible, affordable, and effective digital therapeutics, a platform that is mainstreaming mhealth. A proven solution clinically addressing over 70 percent of long-term health conditions such as COPD, heart disease, or asthma would feature at the Digital Hub.

To provide healthcare providers with easy access to well-researched and peer-reviewed digital health solutions, the platform gives them access to a carefully curated collection of such resources. Digital Hub enhances patient care because, at the end of the day, it is a very accessible and evidence-based alternative to conventional treatment. It comes in a model at less than a cup of coffee in cost per patient year- yes, it is a real game-changing proposition in many dimensions of cost-effectiveness for chronic disease treatment.

The Digital Hub is therefore an important tool for active patient engagement; personalized and interactive interventions give patients an increasingly active role in their health management. A practice-focused approach enables the continued integration of advances in digital therapeutics into daily workflow, thus improving care efficiency and personalization.     

myCOPD: The Digital Solutions for Chronic Obstructive Pulmonary Disease

The myCOPD application is just one example of the innovations in mhealth highlighted by the experts where patients can be empowered to live and manage the disease that is Chronic Obstructive Pulmonary Disease (COPD). The application has been developed specifically for use by COPD experts with input from NHS consultants and possesses a strong functional range designed to help patients take charge of their ailment in as comprehensive a manner as possible.

The application has videos teaching inhaler technique and links to home-based pulmonary rehabilitation. With the addition of the Activity Diary, the app now takes patient engagement to another level, allowing tracking of all daily exercise - walking, cycling, rehab etc. - and sharing it with clinicians.

As such, digital therapeutics gives an empowered feeling to a COPD patient who must self-manage their condition. Such an integrated process between the digital world and the management pathway does improve the patient care outcome while reinforcing the healthcare provider and patient relationship.

Shaping the Future of Healthcare

Through platforms such as Digital Hub and applications such as myCOPD, my mhealth redefines patient care within chronic disease management. By harnessing the capabilities of digital health, the organization tackles the challenges confronted by patients and care providers alike, foreseeing a future in which technology enhances accessibility, efficiency, and outcomes in healthcare. My mhealth's cutting-edge services promise and purport not only to change the way we view health care but also promise many more such things in the future that, ultimately, this becomes the world where we would have ideally wanted to live.

About the Leader

Dr. David Pettigrew, Chief Executive Officer of my mhealth, leads the go to market strategy for my mhealth globally. He has 15 years of experience of digital health and medical device product development, and has taken a number of CE marked and 510k approved products to market in both the US and the EU. He was an early pioneer in integrating smartphone apps with implantable medical device systems, and has served on the leadership team of two global companies who develop digital health solutions for the pharma and medtech industry; Sagentia and BrightInsight. David has a DPhil in molecular biophysics from the University of Oxford.

 “my mhealth's is unlocking the power of affordable digital therapeutics and reshaping the future of patient-centered care. Like a beacon of innovation, it lights the way to a new era where technology and compassion converge for the well-being of all.”